** Ireland-based pharmaceutical company Deepverge Plc
DVRG.L falls 6.6% to 14.25p
** Co expects revenue, for full year to Dec. 31, to be in
excess of 18 mln pounds ($21.9 mln), which is below current
market expectations urn:newsml:reuters.com:*:nASM000MBG
** Also expects "modest" reduction in gross margins for FY
** "There remains uncertainty as to whether the conversion
rate, over the next few months, of prospects into orders for
delivery this calendar year will meet previously expected levels
- co
** As of last close, stock down 35.79% so far this year
(Reporting by Kavya B in Bengaluru)
((Kavya.B@thomsonreuters.com;))